NCT05910606

Brief Summary

Study Description: The investigators propose to extend earlier research conducted during a feasibility study (Strong Foundations 1.0) by enrolling participants who have a greater risk for falling (x4 cohorts of up to 15 individuals) and from a lower socio-economic status (x4 cohorts of up to 15 individuals), and by collecting high quality laboratory based measures of balance, posture, and strength to better determine the effectiveness of the program and its suitability for widespread deployment. Additionally, the investigators hope to showcase it is feasible to sustain programmatic gains with ongoing digitally delivered content by combining cohorts into a larger group that continues to practice the foundational exercises taught during the 12-week initial program.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Sep 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Sep 2023Aug 2026

First Submitted

Initial submission to the registry

May 24, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

June 20, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 16, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2026

Last Updated

December 23, 2025

Status Verified

December 1, 2025

Enrollment Period

2.9 years

First QC Date

May 24, 2023

Last Update Submit

December 19, 2025

Conditions

Outcome Measures

Primary Outcomes (13)

  • Change in the scores from the Short Physical Performance Battery (Balance)

    Change in composite score and individual scores for all components Summary Score 0-12 with higher values being indicative of better performance. Positive change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention. Gait Speed: Measured in m/sec with higher values being indicative of better performance and lower risk Positive change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention 5 repetition chair stands: Scored in seconds with lower values being indicative of better performance and lower risk. Negative change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention Balance: 0-10 seconds with higher time indicative of better balance and lower risk. Positive change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in time to complete the Timed Up and Go (Balance and Function)

    Change in the time to complete a standardized assessment of functional mobility and fall risk that times a participant's ability to get up out of chair, walk 8 feet, navigate an obstacle and return to a seated position Measured in seconds with variable possible length. Faster times are indicative of better performance and lower risk. Negative change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in postural sway during the Better Balance Testing (Balance)

    Changes in the amount of movement (postural sway) observed during a standardized measure of balance on a force platform. This is a well validated measure of proprioceptive and vestibular function utilizing computerized dynamic posturography (i.e. balance board that measures center of pressure and postural sway) Measured in mm of sway with range 0 - ?. Lower scores are indicative of greater stability and lower risk. Negative change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in time to complete a 25 foot walk (Balance and function)

    Change in time to complete a standardized assessment of gait speed and variability commonly used to assess fall risk. Measured in seconds to calculate gait speed in m/sec. Lower times (in sec) and higher speeds (in m/sec) are indicative of better function and lower risk. Negative change scores (T2-BL or T1-BL or T2-T1) for time will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in distance covered during a 2.5 minute walk (Aerobic Capacity)

    Change in the distance (and estimated aerobic capacity derived from distance) on a standardized walk test to measure aerobic endurance and estimate overall capacity Measured in meters with variable range. Higher scores are indicative of greater cardiovascular function and lower risk. Positive change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in Grip Strength (Muscular Strength)

    Change in a Standardized assessment to assess muscular strength. Used because it correlates well with overall body strength. Measured in kg for both hands and averaged with a variable range. Higher scores are indicative of greater muscular strength and lower risk. Positive change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in number of chair stands completed in 30 seconds (Muscular Strength)

    Change in a common field measure associated with fall risk. Used to measure leg strength and endurance specifically.

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in the amount of force generated during isometric assessment of leg strength using BIODEX System 4 PRO (Muscular Strength)

    Change in the amount of force generated during maximal exertion for short time against an immovable object at 3 joint angles to measure hamstring and quadricep strength

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in amount of force generated during isometric assessment of back strength using BIODEX System 4 PRO (Muscular Strength)

    Chage in the amount of force generated during maximal exertion for short time against an immovable object at 3 joint angles to measure strength of the muscles surrounding the lumbar and thoracic spine. Positive change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in Occipital to Wall Distance (Posture)

    Change in common measurement of the curvature of the thoracic and cervical spine done in standing position Score range is in mm and is variable. Higher values indicate more kyphotic curve and are associated with worse outcomes. Negative change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in the number of blocks used for the blocks measurement of Kyphosis (Posture)

    Measurement of the curvature of the thoracic and cervical spine done in a supine position Range 0-7 with higher values indicative of more kyphosis and worse outcomes. Negative change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in height using multiple measures of height (Posture)

    Changes in the difference between height measured while standing "normally" vs. "as tall as possible" to measure height loss due to spinal curvature in the absence of muscular engagement. Measurement in mm of difference with higher scores indicative of greater non specific postural imbalance/deformity and are associated with worse outcomes. Negative change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

  • Change in hip Tilt and Shift (Posture)

    Changes in standardized physical therapy based assessments of left/right and forward/backward symmetry of hips, shoulders and ankles Measured in degrees with a likely range of 0-15. Greater values are indicative of non specific postural imbalance/deformity and are associated with worse outcomes. Negative change scores (T2-BL or T1-BL or T2-T1) will be associated with improved performance following intervention

    Baseline, 12 weeks (post intervention), 24 weeks (post follow up)

Secondary Outcomes (2)

  • System Usability Scale

    12 weeks (post intervention)

  • User Experience

    12 weeks (post intervention)

Study Arms (1)

Exercise Intervention

EXPERIMENTAL

Digitally delivered strength, balance and postural control exercises

Behavioral: Digital Exercise

Interventions

Fall Prevention Program: Our fall- risk reduction program overs digitally delivered exercise with real time feedback from expert instructors.

Exercise Intervention

Eligibility Criteria

Age60 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 60 or older, ambulatory, including with the use of a cane or walker, and able to read and speak English.
  • Completion of the STEADI Stay Independent Questionnaire (with score of 6 or less)
  • Access to internet/computer and Zoom-interface / broadband with a device with a minimum screen size of 7 inches (i.e. tablet or larger).

You may not qualify if:

  • Individuals who are wheel-chair bound
  • Score 7 or more on the STEADI modified questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCSD Health

San Diego, California, 92122, United States

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Clinical Professor

Study Record Dates

First Submitted

May 24, 2023

First Posted

June 20, 2023

Study Start

September 1, 2023

Primary Completion (Estimated)

July 16, 2026

Study Completion (Estimated)

August 31, 2026

Last Updated

December 23, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual data

Locations